HYNE:NASDAQHoyne Bancorp, Inc. Analysis
Data as of 2026-04-09 - not real-time
$15.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hoyne Bancorp (HYNE) is trading at $15.80, just below its 52‑week high of $15.85 and above the 20‑day SMA of $14.59, indicating short‑term momentum. The MACD histogram remains positive (0.10) and the signal line is bullish, while the RSI has climbed to 73, signaling that the stock is approaching overbought territory. Volatility over the past 30 days is elevated at 24% but the beta of 0.36 shows the share moves less than the market, tempering systematic risk. However, the trailing P/E of 526.5 dwarfs the industry average of 17, and the DCF‑derived fair value of $10.41 lies well beneath the current price, flagging a clear overvaluation. Despite this, the price‑to‑book ratio of 0.79 and a solid book value per share of $19.93 suggest a margin of safety from a balance‑sheet perspective. The company reports robust revenue growth of 51% year‑over‑year, yet margins remain thin (profit margin 1.6%) and earnings per share are modest at $0.03.
On the fundamentals side, HYNE carries minimal debt ($3.06 M) and a debt‑to‑equity of essentially zero, reinforcing its financial stability, while cash holdings exceed $48 M. The decreasing volume trend and modest market cap of $118 M raise liquidity concerns, and the regional‑bank sector faces medium regulatory and sector risk. The recent “Extreme Greed” sentiment (fear‑greed index 83.5) may be inflating the price further. Overall, the stock presents a mixed picture: strong top‑line growth and a strong balance sheet are offset by high valuation multiples and limited profitability, suggesting a cautious but potentially rewarding long‑term play.
On the fundamentals side, HYNE carries minimal debt ($3.06 M) and a debt‑to‑equity of essentially zero, reinforcing its financial stability, while cash holdings exceed $48 M. The decreasing volume trend and modest market cap of $118 M raise liquidity concerns, and the regional‑bank sector faces medium regulatory and sector risk. The recent “Extreme Greed” sentiment (fear‑greed index 83.5) may be inflating the price further. Overall, the stock presents a mixed picture: strong top‑line growth and a strong balance sheet are offset by high valuation multiples and limited profitability, suggesting a cautious but potentially rewarding long‑term play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI at 73 indicating overbought conditions
- Price near 52‑week high resistance of $15.85
- Trailing P/E of 526.5 far above industry average
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth of 51% YoY
- Price‑to‑book below 1 suggests a balance‑sheet cushion
- MACD bullish but decreasing volume trend
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low debt and strong book value per share $19.93
- DCF fair value of $10.41 indicates upside if earnings improve
- Regional bank niche with strong community presence
Key Metrics & Analysis
Financial Health
Revenue Growth51.40%
Profit Margin1.58%
P/E Ratio526.5
ROE0.19%
ROA0.05%
P/B Ratio0.8
Op. Cash Flow$1.2M
Industry P/E17.3
Technical Analysis
TrendBullish
RSI73.0
Support$13.86
Resistance$15.85
MA 20$14.59
MA 50$14.49
MA 200$14.33
MACDBullish
VolumeDecreasing
Fear & Greed Index83.46
Valuation
Fair Value$10.41
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.36
Volatility24.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.